Delivery Order SPE2DB22D2206-SPE2DB25FJV72
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product used in the treatment of acromegaly and neuroendocrine tumors. This firm fixed-price delivery order, valued at $48,386.59, represents a competitive award with no set-aside designation and is scheduled for completion by September 4, 2025. The work will be performed at...
- The Defense Logistics Agency's Medical Supply Chain awarded a $10,639.28 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Sandostatin LAR Depot 20 mg kits, with performance completion targeted for July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $19,093.44 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product used in endocrinology treatment. This firm fixed-price, non-set-aside contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents performance from AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. The delivery order is a child contract under...
- The Defense Logistics Agency awarded a $8,146.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 22, 2025. This non-set-aside award represents a competitive procurement executed on August 21, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $20,091.40 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 4, 2025. This firm fixed price contract, awarded on August 1, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $7,979.46 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 20 mg kits. This firm fixed-price, non-competitive delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $63,498.76 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order, which was not set-aside, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sandostatin LAR Depot 20 mg kits under a firm fixed-price contract valued at $21,278.56. This is a competitive award with no set-aside designation, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and an ultimate completion date of August 13, 2025. The delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $7,965.76 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits. The contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $52,498.21 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits. This competitively awarded, firm fixed-price delivery order was issued on August 22, 2025, with a completion date of August 25, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with the agency. The order will be fulfilled from the vendor's corporate office location in Conshohocken,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJV72Delivery Order
The Defense Logistics Agency awarded a $103,639.49 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product used in treating acromegaly and neuroendocrine tumors. This firm fixed price delivery order, issued on September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open competition with no set-aside designation, and performance will be completed by September 10, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare procurement through its comprehensive prime vendor contract with DLA. The company's federal contract portfolio demonstrates extensive experience delivering specialized medications, brand-name and generic pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order supports the broader Defense Health Agency medical supply chain mission, enabling timely pharmaceutical access for military personnel and beneficiaries requiring specialized endocrinology treatments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $103.6k | 9/9/25 |